Rates and predictors for relapse in medication overuse headache: a 1-year prospective study.
about
DHE in the pharmacotherapy of migraine: potential for a larger roleProinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic classMedication-overuse headache: a reviewMedication-overuse headache: epidemiology, diagnosis and treatmentStudy protocol: brief intervention for medication overuse headache--a double-blinded cluster randomised parallel controlled trial in primary care.Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol).Migraine-specific quality of life questionnaire and relapse of medication overuse headacheChronic daily headaches.Multidisciplinary integrated headache care: a prospective 12-month follow-up observational studyMedication-overuse headache.The long-term prognosis of tension-type headache.A narrative review on the management of medication overuse headache: the steep road from experience to evidence.Drug-dependence behaviour and outcome of medication-overuse headache after treatment.Medication-overuse headache: description, treatment, and relapse prevention.Evidence-based understanding of medication-overuse headache: clinical implications.Neurovascular pains: implications of migraine for the oral and maxillofacial surgeon.Management of medication-overuse headache.How clinicians can detect, prevent and treat medication overuse headache.Medication overuse headache: awareness, detection and treatment.Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.Migraine in the triptan era: progresses achieved, lessons learned and future developments.What is the role of dependence-related behavior in medication-overuse headache?Dependent behavior in patients with medication-overuse headache.Treatment of medication-overuse headache: A systematic review.Prognostic factors for chronic headache: A systematic review.Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study.Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: A prospective cohort study.Reduction in medication-overuse headache after short information. The Akershus study of chronic headache.Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol).Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy.Reduction of medication costs after detoxification for medication-overuse headache.Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria.Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up.Update on Medication-Overuse Headache and Its Treatment.Clinical and psychosocial features of frequent relapsers (FR) among patients with chronic migraine and medication overuse.A systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache.Functional-MRI evaluation of pain processing in chronic migraine with medication overuse.Factors associated with a negative outcome of medication-overuse headache: a 3-year follow-up (the 'CARE' protocol).Long-term evolution of chronic daily headache with medication overuse in the general population.
P2860
Q28271614-94AB35CD-E48D-4220-99E9-A8A843E17517Q28292548-5DA7FE06-41E1-4540-BA86-591294EAAA69Q33838844-BCEBDA6A-6499-4266-AE71-104E319B458BQ33949551-CAA78D54-F4B4-457A-9020-E4F93B7C0A62Q34375888-D3BD8F67-D275-4A63-B7CF-7A6FFC2C8FF9Q34885957-97576C5B-602F-43E3-9351-531E083B9C46Q35635689-6D04B682-ABEF-4F54-AFD7-36410C0D3D79Q36239475-D3DF21F8-A86B-4102-B970-3AAE1C51FEB7Q36240299-5A8A7EEE-6B63-49F3-A303-962D82978283Q36311001-A55F5F75-8E31-4B37-917D-4190762AFDACQ36311006-ABF2C2D7-EDBF-410E-94BB-79316DF6500FQ36332629-C0AC18CC-C163-4A4C-BD1C-92814B38C810Q36357131-91367427-74FD-42DB-85BC-C8AD97664BF0Q36405693-7D98C9B7-D3E7-465B-B530-E99857849641Q36641577-DB52C9B7-9CBC-4103-A781-4FA9490CA19AQ36772194-0E90B9FA-44FA-4BEB-9BB3-D6AFA673ADCAQ36941902-2C4F9DAF-9780-4CC8-80C3-8AFF341B2B59Q37317164-5BBAE531-C184-46B6-B5F1-FCCC9EC6A9C2Q37322222-9E4378D8-A062-482F-B1EF-B7BE346D40AEQ37374998-6DEF61BA-6E5B-4690-9CB4-AD0A282E76EAQ37558323-1D2E4D50-2C7F-4860-9BD0-E71FE46EE3F4Q37784245-99437689-5F8F-47D1-9912-976649BE7F55Q37962457-ADF06D10-5174-4411-9E30-5148ADAE26BFQ38540076-FB59AEBF-0CAB-48F0-9F45-30EB260AD542Q38725348-519F5F0A-D3F5-46A5-A1FD-56307AF8E50BQ39175652-94776406-81FD-42CE-B928-49BE9C9C9C63Q39338402-BC7E8229-FA99-43A5-97B9-D55079A6FBD0Q40430237-C4798449-F38F-4F0B-A7A9-0A586618C431Q44284575-02B4C87B-CDA1-40D3-A702-CFFF33CF0633Q45926652-38A5377F-27F3-4D2A-8599-0504539480D0Q46112645-1B6C31BF-A70B-49DB-AD0B-CFF671FDBABAQ46421705-902BEC9C-C3AA-407C-A58B-C173AC21E267Q46849115-DBF2BEF2-FA4E-4827-AF0D-CE6DC3B5E46BQ46987616-AC9D63D5-9EC1-4D3E-99CA-D20893DF23C7Q47635235-A121BEB3-7CB7-49D3-A150-203EF63D7302Q47880975-DAF1094F-F81A-4AAC-BA33-5D47ADF6D7C7Q47965987-0E7328AC-401D-4A3A-81CA-95086A0A2BCDQ48469408-83770E31-8AF6-4581-B69D-BA317E3B58C9Q48509386-829BC68B-9D47-491B-BFCE-CC666315B737Q48859704-49545A7A-7588-4DD2-B412-C93E2C430400
P2860
Rates and predictors for relapse in medication overuse headache: a 1-year prospective study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Rates and predictors for relap ...... e: a 1-year prospective study.
@ast
Rates and predictors for relap ...... e: a 1-year prospective study.
@en
Rates and predictors for relap ...... e: a 1-year prospective study.
@nl
type
label
Rates and predictors for relap ...... e: a 1-year prospective study.
@ast
Rates and predictors for relap ...... e: a 1-year prospective study.
@en
Rates and predictors for relap ...... e: a 1-year prospective study.
@nl
prefLabel
Rates and predictors for relap ...... e: a 1-year prospective study.
@ast
Rates and predictors for relap ...... e: a 1-year prospective study.
@en
Rates and predictors for relap ...... e: a 1-year prospective study.
@nl
P2093
P1433
P1476
Rates and predictors for relap ...... e: a 1-year prospective study.
@en
P2093
P304
P356
10.1212/01.WNL.0000063322.14078.90
P407
P577
2003-05-01T00:00:00Z